[Problems of resistance of the causative agent of melioidosis to antibiotics]

Insights

Melioidosis pathogen (P. pseudomallei) shows high antibiotic resistance. Mutants were created that were more sensitive to tetracycline due to altered lipopolysaccharide structure.

Area of Science:

  • Microbiology
  • Bacterial Genetics
  • Drug Resistance

Background:

  • Melioidosis, a severe infectious disease, is caused by the bacterium Burkholderia pseudomallei.
  • This pathogen exhibits significant intrinsic resistance to various antibiotics, complicating treatment regimens.
  • Understanding the mechanisms of antibiotic resistance in P. pseudomallei is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the genetic basis of antibiotic resistance in P. pseudomallei.
  • To isolate and characterize antibiotic-sensitive mutants of P. pseudomallei.
  • To elucidate the structural changes in lipopolysaccharides associated with altered antibiotic sensitivity.

Main Methods:

  • Chemical mutagenesis of P. pseudomallei using nitrosoguanidine.
  • Isolation and selection of antibiotic-sensitive mutants.
  • Measurement of cell envelope permeability using radiolabeled tetracycline.
  • Analysis of lipopolysaccharide (LPS) composition using gas-liquid chromatography.

Main Results:

  • Mutagenesis successfully generated P. pseudomallei mutants with increased sensitivity to antibiotics.
  • Mutant strains displayed a 3-fold increase in 3H-tetracycline uptake and a 20-fold increase in tetracycline sensitivity compared to the parent strain.
  • Gas-liquid chromatography revealed significant quantitative and qualitative alterations in the sugar components of the LPS in the sensitive mutants.

Conclusions:

  • Lipopolysaccharide structure modifications are linked to increased antibiotic permeability and sensitivity in P. pseudomallei.
  • Targeting LPS biosynthesis or structure could be a potential strategy to overcome antibiotic resistance in melioidosis.
  • Further research into P. pseudomallei LPS is warranted for therapeutic development.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...